RIGEL (RIGL) CEO uses 2,424 shares for tax-withholding, retains large stake

Rhea-AI Filing Summary

RIGEL PHARMACEUTICALS INC CEO and President Raul R. Rodriguez reported a Form 4 transaction involving a tax-related share disposition. On June 1, 2026, 2,424 shares of Common Stock were delivered at $29.86 per share to satisfy tax obligations. After this transaction, Rodriguez directly holds 279,593 shares of Common Stock, indicating the event reflects routine tax withholding rather than an open-market trade.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider RODRIGUEZ RAUL R

Role CEO, President

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	2,424	$29.86	$72K

Holdings After Transaction: Common Stock — 279,593 shares (Direct, null)

Footnotes (1)

Key Figures

Tax-withholding shares: 2,424 shares Share value for tax: $29.86/share Post-transaction holdings: 279,593 shares

3 metrics

Tax-withholding shares 2,424 shares Common Stock delivered to satisfy tax liability on June 1, 2026

Share value for tax $29.86/share Value used for 2,424-share tax-withholding disposition

Post-transaction holdings 279,593 shares Common Stock directly held by Raul R. Rodriguez after transaction

Key Terms

tax-withholding disposition, Form 4, Common Stock

3 terms

tax-withholding disposition financial

"reported a Form 4 transaction involving a tax-related share disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 regulatory

"Raul R. Rodriguez reported a Form 4 transaction"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"2,424 shares of Common Stock were delivered"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RODRIGUEZ RAUL R

(Last) (First) (Middle)

RIGEL PHARMACEUTICALS, INC.

611 GATEWAY BLVD, SUITE 900

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RIGEL PHARMACEUTICALS INC [ RIGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		F		2,424	D	$29.86	279,593	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Raymond Furey (Attorney-in-Fact)	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did RIGL CEO Raul Rodriguez report on this Form 4?

Raul R. Rodriguez reported a tax-withholding disposition of 2,424 shares of RIGEL PHARMACEUTICALS INC Common Stock. The shares were used to cover tax obligations, rather than representing an open-market purchase or sale of the company’s stock.

At what price were the RIGEL (RIGL) shares valued in the tax-withholding transaction?

The 2,424 RIGEL shares were valued at $29.86 per share in the tax-withholding disposition. This price reflects the value used for satisfying the tax liability, not necessarily an executed open-market trade price on an exchange.

How many RIGL shares does Raul Rodriguez hold after this Form 4 transaction?

Following the tax-withholding disposition, Raul R. Rodriguez directly holds 279,593 shares of RIGEL PHARMACEUTICALS INC Common Stock. This updated holding reflects his remaining direct ownership position after delivering shares to cover his tax obligations.

Does this RIGEL (RIGL) Form 4 indicate an open-market sale by the CEO?

No. The Form 4 shows a tax-withholding disposition, coded “F,” where 2,424 shares were delivered to pay tax liabilities. This type of transaction is a mechanical tax event, not an open-market sale or discretionary trading decision by the CEO.

What does transaction code F mean for the RIGL Form 4 filing?

Transaction code F indicates “payment of exercise price or tax liability by delivering securities.” For RIGEL PHARMACEUTICALS INC, it means 2,424 shares were used to satisfy the CEO’s tax obligation, rather than being bought or sold on the open market.